PPAPDC3 Antibody Blocking Peptide

• Reactivity: Hu
• Applications: AC
• Concentration: 0.2 mg/ml

PPAPDC3 Antibody Blocking Peptide Summary

• Description: A blocking peptide containing 19 amino acids near the amino terminus of human PPAPDC3.

  Source: Synthetic

  (Accession #: EAW87966)

• Source: Synthetic
• Protein/Peptide Type: Antibody Blocking Peptide
• Gene: PLPP7
• Purity: N/A

Applications/Dilutions

• Dilutions:
  • Antibody Competition
• Application Notes: This peptide is useful as a blocking peptide for NBP1-76246.
  
  For further blocking peptide related protocol, click here.

Packaging, Storage & Formulations

• Storage: Store at -20C. Avoid freeze-thaw cycles.
• Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• Preservative: 0.02% Sodium Azide
• Concentration: 0.2 mg/ml
• Purity: N/A

Alternate Names for PPAPDC3 Antibody Blocking Peptide

• C9orf67
• chromosome 9 open reading frame 67
• EC 3.1.3
• EC 3.1.3.-
• FLJ14662
• KIAA0515
• MGC12921
• NET39
• phosphatidic acid phosphatase type 2 domain containing 3
• Phosphatidic acid phosphatase type 2 domain-containing protein 3
• probable lipid phosphate phosphatase PPAPDC3

Background

PPAPDC3 plays a role as negative regulator of myoblast differentiation, in part through effects on MTOR signaling.Has no detectable enzymatic activity

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: PLPP7